Ocugen Inc (NASDAQ:OCGN) shares, rose in value, with the stock price down by -2.72% to the previous day’s close as strong demand from buyers drove the stock to $0.74.
Actively observing the price movement in the recent trading, the stock is buoying the session at $0.76, falling within a range of $0.73 and $0.7544. The value of beta (5-year monthly) is 3.766. Referring to stock’s 52-week performance, its high was $2.11, and the low was $0.50. On the whole, OCGN has fluctuated by -4.19% over the past month.
With the market capitalization of Ocugen Inc currently standing at about $214.33 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 300k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that OCGN’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of OCGN currently trading nearly -6.87% and -14.18% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.27, while the 7-day volatility ratio is showing 5.77% which for the 30-day chart, stands at 8.45%. Furthermore, Ocugen Inc (OCGN)’s beta value is 3.81, and its average true range (ATR) is 0.06.
A comparison of Ocugen Inc (OCGN) with its peers suggests the former has fared considerably weaker in the market. OCGN showed an intraday change of -2.72% in today’s session so far, and over the past year, it grew by 37.80%%.
Data on historical trading for Ocugen Inc (NASDAQ:OCGN) indicates that the trading volumes over the past 10 days have averaged 4.59 and over the past 3 months, they’ve averaged 4.79 million. According to company’s latest data on outstanding shares, there are 290.26 million shares outstanding.
Nearly 1.80% of Ocugen Inc’s shares belong to company insiders and institutional investors own 27.56% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 52.26 million shares as on 2024-12-31, resulting in a short ratio of 9.49. According to the data, the short interest in Ocugen Inc (OCGN) stood at 1824.00 of shares outstanding as of 2024-12-31; the number of short shares registered in 2024-11-29 reached 57.0 million. The stock has fallen by -8.61% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the OCGN stock heading into the next quarter.
